Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging

NMR in Biomedicine

Volumn 18, Issue 8, 2005, Pages 570-576

  Jensen, J Eric ^a,b   de B Frederick, Blaise ^a,b   Renshaw, Perry F ^a,b,c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Aminobutyric acid; Brain; Grey matter; Spectroscopic imaging; White matter

Indexed keywords

BIOCHEMISTRY; IMAGE SEGMENTATION; MEDICAL IMAGING; NEUROPHYSIOLOGY; PATHOLOGY; REGRESSION ANALYSIS; SPECTROSCOPIC ANALYSIS; TISSUE;

GREY MATTER; HUMAN BRAIN; NEUROCHEMICAL PATHOLOGY; SPECTROSCOPIC-IMAGING; WHITE MATTER;

BRAIN;

4 AMINOBUTYRIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; AMINO ACID ANALYSIS; ARTICLE; BRAIN CORTEX; BRAIN RADIOGRAPHY; BRAIN TISSUE; EX VIVO STUDY; FEMALE; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; IN VIVO STUDY; LINEAR REGRESSION ANALYSIS; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; WHITE MATTER;

ANIMALS; BRAIN; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; REGRESSION ANALYSIS;

ANIMALIA;

EID: 29544439102     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.994     Document Type: Article

References (43)

1. 1H-magnetic resonance spectroscopy. Arch. Gen. Psychiatry 2001; 58: 556-561.
2. Epperson CN, O'Malley S, Czarkowski KA, Gueorguieva R, Jatlow P, Sanacora G, Rothman DL, Krystal JH, Mason GF. Sex, GABA and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol. Psychiatry 2005; 57: 44-48.
3. Simister RJ, McLean MA, Barker GJ, Duncan JS. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology 2003; 61: 897-902.
4. Chang L, Cloak CC, Ernst T. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J. Clin. Psychiatry 2003; 64(Suppl 3): 7-14.
5. Petroff OA, Ogino T, Alger JR. High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J. Neurochern. 1988; 51: 163-171.
6. Petroff OA, Spencer DD, Alger JR, Prichard JW. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989; 39: 1197-1202.
7. Pan JW, Twieg DB, Hetherington HP. Quantitative spectroscopic imaging of the human brain. Magn. Reson. Med. 1998; 40: 363-369.
8. 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn. Reson. Med. 1996; 36: 21-29.
9. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF, Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 2004; 61: 450-458.
10. 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc. Natl. Acad. Sci. USA 1993; 90: 5662-5666.
11. Hetherington HP, Newcomer BR, Pan JW. Measurements of human cerebral GABA at 4.1 T using numerically optimized editing pulses. Magn. Reson. Med. 1998; 39: 6-10.
12. Keltner JR, Wald LL, Christensen JD, Maas LC, Moore CM, Cohen BM, Renshaw PF. A technique for detecting GABA in the human brain with PRESS localization and optimized refocusing spectral editing radiofrequency pulses. Magn. Reson. Med. 1996; 36: 458-461.
13. Keltner JR, Wald LL, Frederick BD, Renshaw PF. In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn. Reson. Med. 1997; 37: 366-371.
14. de Graaf RA, Rothman DL. Detection of gamma-aminobutyric acid (GABA) by longitudinal scalar order difference editing. J. Magn. Reson. 2001; 152: 124-131.
15. Shen J, Rothman DL, Brown P. In vivo GABA editing using a novel doubly selective multiple quantum filter. Magn. Reson. Med 2002; 47: 447-454.
16. McLean MA, Busza AL, Wald LL, Simister RJ, Barker GJ, Williams SR. In vivo GABA + measurement at 1.5 T using a PRESS-localized double quantum filter. Magn. Reson. Med. 2002; 48: 233-241.
17. Ke Y, Cohen BM, Bang JY, Yang M, Renshaw PF. Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res. 2000; 100: 169-178.
18. Choi I-Y, Lee S-P, Merkle H, Shen J. In vivo detection of gray and white matter differences in GABA concentration in the human brain using chemical shift imaging of GABA. Proc. Int. Soc. Magn. Reson. Med. 2004; 11: 109.
19. Lee S-P Shen J, Hu X, Choi I-Y SLIM-based multiple quantum chemical shift imaging for the measurement of GABA in the human brain in vivo. Proc. Int. Soc. Magn. Reson. Med. 2005; 13: 349.
20. Shen J, Shungu DC, Rothman DL. In vivo chemical shift imaging of gamma-aminobutyric acid in the human brain. Magn. Reson. Med. 1999; 41: 35-42.
21. Jensen JE, Frederick B, Wang L, Brown J, Renshaw P. Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 tesla in the human brain. Magn. Reson. Med. 2005; 54(4): 783-788.
22. Spielman DM, Glover GH, Macovski A, Pfefferbaum A. Magnetic resonance spectroscopic imaging of ethanol in the human brain: a feasibility study. Alcohol Clin. Exp. Res. 1993; 17: 1072-1077.
23. Pan JW, Mason GF, Pohost GM, Hetherington HP. Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1 T. Magn. Reson. Med. 1996; 36: 7-12.
24. 1H magnetic resonance spectroscopic imaging. Magn. Reson. Med. 2001; 45: 899-907.
25. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 1997; 49: 1513-1521.
26. Schuff N, Amend DL, Meyerhoff DJ, Tanabe JL, Norman D, Fein G, Weiner MW. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 1998; 207: 91-102.
27. Schuff N, Rooney WD, Miller R, Gelinas DF, Amend DL, Maudsley AA, Weiner MW. Reanalysis of multislice H MRSI in amyotrophic lateral sclerosis. Magn. Reson. Med. 2001; 45: 513-516.
28. Ryner LN, Sorenson JA, Thomas MA. 3D localized 2D NMR spectroscopy on an MRI scanner. J. Magn. Reson. B 1995; 107: 126-137.
29. Ryner LN, Sorenson JA, Thomas MA. Localized 2D J-resolved 1H MR spectroscopy: strong coupling effects in vitro and in vivo. Magn. Reson. Imaging 1995; 13: 853-869.
30. Dreher W, Leibfritz D. On the use of two-dimensional-J NMR measurements for in vivo proton MRS: measurement of homonuclear decoupled spectra without the need for short echo times. Magn. Reson. Med. 1995; 34: 331-337.
31. Kreis R, Boesch C. Spatially localized, one- and two-dimensional NMR spectroscopy and in vivo application to human muscle. J. Magn. Reson. B 1996; 113: 103-118.
32. 31P spectroscopic imaging with improved sensitivity, resolution and sidelobe suppression. J. Magn. Reson. B 1994; 104: 85-88.
33. Jensen JE, Drost DJ, Menon RS, Williamson PC. In vivo brain P-MRS: measuring the phospholipid resonances at 4 tesla from small voxels. NMR Biomed. 2002; 15: 338-347.
34. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993; 30: 672-679.
35. 1H spectra with LCModel. NMR Biomed. 2001; 14: 260-264.
36. 2 in high-resolution spectroscopic images of brain. J. Magn. Reson. B 1995; 107: 68-73.
37. Hetherington HP, Mason GF, Pan JW, Ponder SL, Vaughan JT, Twieg DB, Pohost GM. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1 T. Magn. Reson. Med. 1994; 32: 565-571.
38. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn. Reson. Med. 1993; 30: 424-437.
39. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993; 187: 219-227.
40. 1H NMR spectra of human brain. Magn. Reson. Med. 1994; 32: 294-302.
41. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13: 129-153.
42. Hiba B, Serduc R, Provent P, Farion R, Remy C, Ziegler A. 2D J-resolved spiral spectroscopic imaging at 7 T: application to mobile lipid mapping in a rat glioma. Magn. Reson. Med. 2004; 52: 658-662.
43. Adalsteinsson E, Spielman DM. Spatially resolved two-dimensional spectroscopy. Magn. Reson. Med. 1999; 41: 8-12.